.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

FDA approves first cell-culture vaccine for seasonal influenza

November 26, 2012

FDA approved Influenza Virus Vaccine (Flucelvax, Novartis Vaccines), the first cell-culture-derived vaccine, for individuals aged 18 years of age and older.